Disclaimer

Please note that you are now entering a website directly or indirectly maintained by a third party (the "External Site") and that you do so at your own risk.

Please note that you are now entering a website directly or indirectly maintained by a third party (the "External Site") and that you do so at your own risk.

By clicking “Accept” you acknowledge and agree that neither ITGR nor third party provider Virtua Research, Inc. (“Virtua) is responsible, or accepts or assumes any responsibility or liability whatsoever for, the content, the data or the technical operation of the Linked Site. Further, by entering the External Site, you also acknowledge and agree that you completely and irrevocably waive any and all rights and claims against ITGR and Virtua and further acknowledge and agree that in no event shall ITGR or Virtua, its officers, employees, directors and agents be liable for any (i) indirect, consequential, incidental, special, compensatory or punitive damages, (ii) damages for loss of income, loss of business profits, business interruption, loss of data or business information, loss of or damage to property, (iii) claims of third parties, or (iv) other pecuniary loss, arising out of or related to this disclaimer or the External Site

By entering the External Site, you further acknowledge and agree that the disclaimer of warranties and limitations of liability set out in this disclaimer shall apply regardless of the causes, circumstances or form of action giving rise to the loss, damage, claim or liability, even if such loss, damage, claim or liability is based upon breach of contract (including, without limitation, a claim of fundamental breach or breach of a fundamental term), tort (including, without limitation, negligence), strict liability or any other legal or equitable theory, and even if ITGR and Virtua are advised of the possibility of the loss, damage, claim or liability. The waiver and release specifically includes, without limitation, any and all rights and claims pertaining to the processing of personal data, including but not limited to any rights under any applicable data protection statute(s).

If in any jurisdiction, any part of this disclaimer is held to be unenforceable by a court of competent jurisdiction, such part of this disclaimer shall be restricted or eliminated to the minimum extent and the remaining disclaimer shall otherwise remain in full force and effect.

Please note the information presented is deemed representative at the time of its original release. Changes in historical information may occur due to adjustments in accounting and reporting standards & procedures.

Non-GAAP Information

In addition to disclosing results determined in accordance with GAAP, ITGR may also disclose certain non-GAAP and pro forma non-GAAP results of operations, including certain ratios, operational and miscellaneous data, as well as net income, diluted earnings per share, operating expenses, and operating income that make certain adjustments or exclude certain charges and gains that are outlined in the schedules included in this website. Management believes that this non-GAAP and pro forma non-GAAP information provides investors with additional information to assess ITGR operating performance by making certain adjustments or excluding costs or gains and assists investors in comparing our operating performance to prior periods. Management uses this non-GAAP and pro forma non-GAAP information, along with GAAP information, in evaluating its historical operating performance. ITGR and Virtua also take no responsibility for third party pricing data provided for informational purposes and certain ratio results formulated from the provided third party pricing data.

The non-GAAP information is not prepared in accordance with GAAP and may not be comparable to non-GAAP information used by other companies. The non-GAAP information should not be viewed as a substitute for, or superior to, other data prepared in accordance with GAAP.

Greatbatch Announces Engagement to Advance Medical Device Strategy

February 27, 2012

CLARENCE, N.Y.--(BUSINESS WIRE)--Feb. 27, 2012-- Greatbatch, Inc. announced the company has engaged Abel Ang as senior advisor to Greatbatch President and CEO, Thomas J. Hook. In that role, Ang will provide guidance relative to the commercialization of QiG medical device technologies into the health care markets of emerging countries and also help to advise on Greatbatch’s expansion into Asia.

“In 2008, Greatbatch launched a strategy to move our company forward and evolve from not only being an innovative component manufacturer but also being an innovative medical device company,” said Thomas J. Hook, President and CEO. “Abel’s background and experience will serve the company well as we continue our evolution and look to partner with entities in emerging markets to execute our strategy.”

Abel Ang was formerly President, Asia/Pacific for Hill-Rom Inc, a medical devices company, where he was responsible for expanding Hill-Rom’s presence in the high growth Asia/Pacific markets. He previously served as the Chief Technology Officer for Hill-Rom, where he had overall responsibility for Hill-Rom’s global R&D operations distributed across sites in the U.S., Mexico, France, and Singapore. He was also Vice-President and General Manager of Hill-Rom’s $420M Global Surfaces and Therapy Business Unit in addition to other business development positions with the company.

Prior to joining Hill-Rom, Ang headed the global Medical Technology and Biotechnology industry groups in the Singapore Economic Development Board’s (EDB) Biomedical Division and spent several years in EDB’s European Operations based in Frankfurt, Germany. He currently sits on the Board of Exploit Technologies which provides access to Singapore's largest pool of intellectual property and knowledge generated by over 2,000 researchers at A*STAR's research institutes, and on the Advisory Board of the Singapore-MIT Alliance Innovation Grant.

About Greatbatch, Inc.

Greatbatch, Inc. (NYSE: GB) provides top-quality technologies to industries that depend on reliable, long-lasting performance through its brands Greatbatch Medical, Electrochem and QiG Group. Greatbatch Medical develops and manufactures critical medical device technologies for the cardiac, neurology, vascular and orthopaedic markets. Electrochem designs and manufactures battery and wireless sensing technologies for high-end niche applications in the energy, military, portable medical, and other markets. The QiG Group empowers the design and development of new medical devices for our core markets. Additional information about the Company is available at www.greatbatch.com.

Source: Greatbatch, Inc.

Greatbatch, Inc.
Christopher Knospe, 716-759-5727
cknospe@greatbatch.com